Pubblicazioni

Brain insulin resistance: An early risk factor for Alzheimer's disease development in down syndrome

2022 - NEURAL REGENERATION RESEARCH

Aberrant crosstalk between insulin signaling and mTOR in young Down syndrome individuals revealed by neuronal-derived extracellular vesicles

2021 - ALZHEIMER'S & DEMENTIA

Perluigi, M.; Picca, A.; Montanari, E.; Calvani, R.; Marini, F.; Matassa, R.; Tramutola, A.; Villani, A.; Familiari, G.; Domenico, F. D.; Butterfield, D. A.; Oh, K. J.; Marzetti, E.; Valentini, D.; Barone, E.

Building the future therapies for down syndrome: the third international conference of the T21 research society

2021 - MOLECULAR SYNDROMOLOGY

Dierssen, M.; Herault, Y.; Helguera, P.; Martinez De Lagran, M.; Vazquez, A.; Christian, B.; Carmona-Iragui, M.; Wiseman, F.; Mobley, W.; Fisher, E. M. C.; Brault, V.; Esbensen, A.; Jacola, L. M.; Potier, M. C.; Hamlett, E. D.; Abbeduto, L.; Del Hoyo Soriano, L.; Busciglio, J.; Iulita, M. F.; Crispino, J.; Malinge, S.; Barone, E.; Perluigi, M.; Costanzo, F.; Delabar, J. M.; Bartesaghi, R.; Dekker, A. D.; De Deyn, P.; Fortea Ormaechea, J.; Shaw, P. A.; Haydar, T. F.; Sherman, S. L.; Strydom, A.; Bhattacharyya, A.